Opdyta Solution For Infusion
4ml Solution For Infusion in VialMRP ₹43780.00
₹43780.00
Made by
BRISTOL-MYERS SQUIBB PVT LTD
Dosage
SOLUTION FOR INFUSION
Expiry
Product Summary
| Salt Content | Nivolumab(10.0 Mg/Ml) |
| Uses | Various types of cancer, including melanoma, lung cancer, kidney cancer, and Hodgkin lymphoma |
| Therapy | Anti-neoplastic |
| Side effects | Fatigue, nausea, skin rash, itching, loss of appetite, diarrhea, constipation, joint pain, and headache |
Assurance
available
Regulated
Medical Description
Opdyta solution for infusion contains nivolumab, a medication used to treat various cancers like skin, lung, and kidney cancer. It works by boosting the immune system's ability to fight cancer by blocking molecules that suppress its activity.
Opdyta solution for infusion is not suitable for everyone. People with severe allergies to the drug or certain autoimmune diseases like lupus shouldn't use it. Patients with organ transplants also need to be cautious.
Common side effects may include rash, weakness, and headache. Make sure to inform your doctor about any existing lung, liver, or kidney issues, as well as all medications you are currently taking, since they may interact with Opdyta solution for infusion. This medication is not recommended for use during pregnancy or breastfeeding, and it is crucial for both partners to use effective contraception during treatment.
Uses
Contraindications
Side effects
- Infections and infestations: upper respiratory tract infection.
- Blood and lymphatic system disorders: lymphopenia, anaemia, leukopenia, neutropenia, and thrombocytopenia.
- Immune system disorders: infusion-related reactions, such as cytokine release syndrome. Endocrine disorders involve hypothyroidism.
- Metabolism and nutrition disorders: hyperglycemia, decreased appetite, hyponatremia, hypoalbuminemia, hypocalcemia, hypomagnesemia, hypokalemia, and hypercalcemia.
- Nervous system disorders: headache. Respiratory, thoracic, and mediastinal disorders involve dyspnea and cough.
- Gastrointestinal disorders: diarrhoea, vomiting, nausea, abdominal pain, and constipation.
- Skin and subcutaneous tissue disorders: rash and pruritus.
- Musculoskeletal and connective tissue disorders: musculoskeletal pain and arthralgia.
- General disorders and administration site conditions: fatigue and pyrexia.
- Hepatobiliary and renal disorders are marked by increased AST, ALT, alkaline phosphatase, creatinine, lipase, and amylase levels.
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have any history of autoimmune diseases (e.g., rheumatoid arthritis, lupus, inflammatory bowel disease).
- You have a history of serious infections.
- You have had a recent organ transplant.
- You have active brain metastases (unless treated).
- You have significant lung problems.
- You have a history of severe allergic reactions.
- You are pregnant or planning to become pregnant.
- You are breastfeeding.
- You are taking any other medications, including over-the-counter drugs and herbal supplements, as they may interact with Opdyta solution for infusion.
- You have had any previous severe side effects with other cancer treatments.
- You have had a previous severe infusion reaction with Opdyta solution for infusion or similar medications.
Directions for Use
Storage and disposal
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:OPDYTA
Manufacturer Name:BRISTOL-MYERS SQUIBB PVT LTD
Address:Bristol Myers Squibb S.R.L Loc. Fontana del Ceraso, 03012 Anagni (FR), Italy
Country of Origin:Italy
Vendor Details
Fulfillment Information: Opdyta 10 MG/ML Solution For Infusion (4) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- OPDIVO 10 mg/mL concentrate for solution for infusion - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2025 [cited 6 January 2025]
- Bristol-Myers Squibb. Opdyta solution for infusion (nivolumab) prescribing information [Internet]. India: Bristol-Myers Squibb; [cited 2025 Jan 20].
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
